Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-10

Clinical Trial Update: Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combination of stem cells and electromagnetic stimulation for toxic optic neuropathy due to methanol poisoning; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnetic field exposure therapy (electromagnetic stimulation)
  • Stem cell therapy (stem cell)

Snippet

Sponsor: Ankara Universitesi Teknokent | Conditions: Methanol Poisoning, Toxic Optic Neuropathy | Phase 3 | Status: COMPLETED